{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:11:59Z","timestamp":1778767919844,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.endien.2026.501825","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:29:58Z","timestamp":1778765398000},"page":"501825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipodystrophies: A diagnostic and therapeutic challenge"],"prefix":"10.1016","volume":"73","author":[{"given":"David","family":"Ara\u00fajo-Vilar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00eda","family":"Fern\u00e1ndez-Pombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2026.501825_bib0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40618-018-0887-z","article-title":"Diagnosis and treatment of lipodystrophy: a step-by-step approach","volume":"42","author":"Ara\u00fajo-Vilar","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.endien.2026.501825_bib0010","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1111\/dom.15061","article-title":"Clinical features of generalized lipodystrophy in Turkey: a cohort analysis","volume":"25","author":"Simsir","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.endien.2026.501825_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1250203","article-title":"Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain","volume":"14","author":"Fern\u00e1ndez-Pombo","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.endien.2026.501825_bib0020","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501825_bib0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s42000-022-00386-7","article-title":"Lipodystrophy-associated progeroid syndromes","volume":"21","author":"Ara\u00fajo-Vilar","year":"2022","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.endien.2026.501825_bib0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12020-016-1002-x","article-title":"Type 1 familial partial lipodystrophy: understanding the Kobberling syndrome","volume":"54","author":"Guill\u00edn-Amarelle","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.endien.2026.501825_bib0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11892-025-01603-4","article-title":"Clinical guidance for lipodystrophy syndromes: from diagnosis and work-up to treatment","volume":"25","author":"Gilio","year":"2025","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.endien.2026.501825_bib0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13023-020-01364-1","article-title":"LipoDDx: a mobile application for identification of rare lipodystrophy syndromes","volume":"15","author":"Ara\u00fajo-Vilar","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.endien.2026.501825_bib0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ajmg.a.37880","article-title":"Homozygous LIPE mutation in siblings with multiple symmetric lipomatosis, partial lipodystrophy, and myopathy","volume":"173","author":"Zolotov","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.endien.2026.501825_bib0050","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23813","article-title":"Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression","volume":"6","author":"Rocha","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.endien.2026.501825_bib0055","article-title":"A recurrent ACAA2 variant causes a dominant syndrome of lipodystrophy, lipomatosis, infantile steatohepatitis, and hypoglycemia","volume":"136","author":"Simha","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.endien.2026.501825_bib0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2337\/db21-1086","article-title":"Characterization and clinical association of autoantibodies against perilipin 1 in patients with acquired generalized lipodystrophy","volume":"72","author":"Corvillo","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.endien.2026.501825_bib0065","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgag126","article-title":"Evaluating the therapeutic impact of tirzepatide in people with partial lipodystrophy","author":"Mandour","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501825_bib0070","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2337\/dc06-0130","article-title":"Effectiveness of gastric bypass surgery in a patient with familial partial lipodystrophy","volume":"29","author":"Utzschneider","year":"2006","journal-title":"Diabetes Care"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253001802600096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253001802600096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:30:09Z","timestamp":1778765409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S253001802600096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S253001802600096X"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2026.501825","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipodystrophies: A diagnostic and therapeutic challenge","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2026.501825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501825"}}